Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S M Mikulski

Showing results (11-20 of 36) with videos related to

Pageof 4
Sort By:
Cell and Tissue Kinetics|May 1, 1990
Tamoxifen and trifluoroperazine (Stelazine) potentiate cytostatic/cytotoxic effects of P-30 protein, a novel protein possessing anti-tumor activityS M Mikulski, A Viera, W Ardelt, et al.
Experimental Cell Research|February 27, 1999
Cell cycle-related differences in susceptibility of NIH/3T3 cells to ribonucleasesM R Smith, D L Newton, S M Mikulski, et al.
Journal of the National Cancer Institute|January 17, 1990
Striking increase of survival of mice bearing M109 Madison carcinoma treated with a novel protein from amphibian embryosS M Mikulski, W Ardelt, K Shogen, et al.
Anticancer Research|May 16, 2000
Enhanced cellular radiation sensitivity of androgen-independent human prostate tumor cells by onconaseI Lee, Y H Lee, S M Mikulski, et al.
The Journal of Biological Chemistry|May 15, 1993
A cytotoxic ribonuclease. Study of the mechanism of onconase cytotoxicityY Wu, S M Mikulski, W Ardelt, et al.
Transplantation|February 1, 1977
Depressed effector cell function in antibody-dependent cell-mediated cytotoxicity in kidney allograft recipientsE Dupont, G Opelz, L A Gustafsson, et al.
Cell and Tissue Kinetics|May 1, 1988
Cytostatic and cytotoxic effects of Pannon (P-30 Protein), a novel anticancer agentZ Darzynkiewicz, S P Carter, S M Mikulski, et al.
Journal of Surgical Oncology|March 30, 2000
Tumoricidal effects of onconase on various tumorsI Lee, Y H Lee, S M Mikulski, et al.
Cancer Research|September 15, 1996
Molecular determinants in the plasma clearance and tissue distribution of ribonucleases of the ribonuclease A superfamilyV M Vasandani, Y N Wu, S M Mikulski, et al.
Investigational New Drugs|September 20, 2001
A phase II trial of weekly intravenous ranpirnase (Onconase), a novel ribonuclease in patients with metastatic kidney cancerN J Vogelzang, M Aklilu, W M Stadler, et al.
Pageof 4

Showing results (11-20 of 36) with videos related to

Sort By:
Pageof 4
Cell and Tissue Kinetics|May 1, 1990
Tamoxifen and trifluoroperazine (Stelazine) potentiate cytostatic/cytotoxic effects of P-30 protein, a novel protein possessing anti-tumor activityS M Mikulski, A Viera, W Ardelt, et al.
Experimental Cell Research|February 27, 1999
Cell cycle-related differences in susceptibility of NIH/3T3 cells to ribonucleasesM R Smith, D L Newton, S M Mikulski, et al.
Journal of the National Cancer Institute|January 17, 1990
Striking increase of survival of mice bearing M109 Madison carcinoma treated with a novel protein from amphibian embryosS M Mikulski, W Ardelt, K Shogen, et al.
Anticancer Research|May 16, 2000
Enhanced cellular radiation sensitivity of androgen-independent human prostate tumor cells by onconaseI Lee, Y H Lee, S M Mikulski, et al.
The Journal of Biological Chemistry|May 15, 1993
A cytotoxic ribonuclease. Study of the mechanism of onconase cytotoxicityY Wu, S M Mikulski, W Ardelt, et al.
Transplantation|February 1, 1977
Depressed effector cell function in antibody-dependent cell-mediated cytotoxicity in kidney allograft recipientsE Dupont, G Opelz, L A Gustafsson, et al.
Cell and Tissue Kinetics|May 1, 1988
Cytostatic and cytotoxic effects of Pannon (P-30 Protein), a novel anticancer agentZ Darzynkiewicz, S P Carter, S M Mikulski, et al.
Journal of Surgical Oncology|March 30, 2000
Tumoricidal effects of onconase on various tumorsI Lee, Y H Lee, S M Mikulski, et al.
Cancer Research|September 15, 1996
Molecular determinants in the plasma clearance and tissue distribution of ribonucleases of the ribonuclease A superfamilyV M Vasandani, Y N Wu, S M Mikulski, et al.
Investigational New Drugs|September 20, 2001
A phase II trial of weekly intravenous ranpirnase (Onconase), a novel ribonuclease in patients with metastatic kidney cancerN J Vogelzang, M Aklilu, W M Stadler, et al.
Pageof 4